表紙
市場調查報告書

寡核苷酸合成的全球市場:試劑&消耗品、設備、合成寡核苷酸

Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides; Application; End User) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

出版商 Transparency Market Research 商品編碼 535885
出版日期 內容資訊 英文 187 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
寡核苷酸合成的全球市場:試劑&消耗品、設備、合成寡核苷酸 Oligonucleotide Synthesis Market (Product - Reagents & Consumables, Equipment, and Synthesized Oligonucleotides; Application; End User) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
出版日期: 2017年07月13日內容資訊: 英文 187 Pages
簡介

本報告提供全球寡核苷酸合成的市場調查,市場及技術定義和概要,市場成長的各種影響因素及市場機會分析,各產品類型、用途、終端用戶、地區/主要國家趨勢與市場規模的變化與預測,競爭環境,以及主要企業的簡介等彙整。

第1章 序文

第2章 前提條件、調查手法

第3章 摘要整理

第4章 市場概要

  • 簡介
    • 各產品類型定義
    • 產業的演進、發展
  • 概要
  • 主要市場指標
  • 市場動態
    • 成長推動因素
    • 阻礙成長要素
    • 市場機會
  • 市場分析、預測
    • 市場收益預測
  • 全球供需方案
  • 波特的五力分析
  • 價值鏈分析
  • 市場展望
  • 寡核苷酸的各種用途
  • PEST分析
  • 開發平台分析

第5章 市場分析、預測:各產品類型

  • 簡介、定義
  • 主要調查結果、發展趨勢
  • 主要趨勢
  • 市場預測:各產品類型
    • 試劑、消耗品
    • 設備
    • 合成寡核苷酸
      • DNA寡核苷酸
      • RNA寡核苷酸
      • 其他
  • 市場魅力

第6章 市場分析、預測:各用途

  • 簡介、定義
  • 主要調查結果、發展趨勢
  • 主要趨勢
  • 市場預測:各用途
    • 研究
      • 聚合酵素鏈鎖反應 (PCR)
      • 次世代定序
      • 其他
    • 治療
      • 反義寡核苷酸
      • 核酸核酸適體
    • 診斷
  • 市場的各魅力用途

第7章 市場分析、預測:各終端用戶

  • 簡介、定義
  • 主要調查結果、發展趨勢
  • 主要趨勢
  • 市場預測:各終端用戶
    • 生物科技&醫藥品企業
    • 研究機關
    • 診斷實驗室
  • 市場魅力

第8章 市場分析、預測:各地區

  • 主要調查結果
  • 製作、法律規章
  • 市場規模的預測
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東、非洲
  • 市場魅力

第9章 北美市場分析、預測

  • 簡介
    • 主要調查結果
    • 主要趨勢
  • 市場預測:各產品類型
  • 市場預測:各用途
  • 市場預測:各終端用戶
  • 市場預測:各國
    • 美國
    • 加拿大
  • 市場魅力分析

第10章 歐洲市場分析、預測

  • 簡介
    • 主要調查結果
    • 主要趨勢
  • 市場預測:各產品類型
  • 市場預測:各用途
  • 市場預測:各終端用戶
  • 市場預測:各國
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 市場魅力分析

第11章 亞太地區市場分析、預測

  • 簡介
    • 主要調查結果
    • 主要趨勢
  • 市場預測:各產品類型
  • 市場預測:各用途
  • 市場預測:各終端用戶
  • 市場預測:各國
    • 中國
    • 印度
    • 日本
    • 澳洲 & 紐西蘭
    • 其他
  • 市場魅力分析

第12章 南美市場分析、預測

  • 簡介
    • 主要調查結果
    • 主要趨勢
  • 市場預測:各產品類型
  • 市場預測:各用途
  • 市場預測:各終端用戶
  • 市場預測:各國
    • 巴西
    • 墨西哥
    • 其他
  • 市場魅力分析

第13章 中東、非洲市場分析、預測

  • 簡介
    • 主要調查結果
    • 主要趨勢
  • 市場預測:各產品類型
  • 市場預測:各用途
  • 市場預測:各終端用戶
  • 市場預測:各國
    • 沙烏地阿拉伯
    • 南非
    • UAE
    • 其他
  • 市場魅力分析

第14章 競爭環境

  • 主要企業:競爭矩陣
  • 企業佔有率分析
  • 企業簡介
    • GE Healthcare
    • Thermo Fisher Scientific
    • Agilent Technologies, Inc.
    • Merck KGaA
    • Integrated DNA Technologies, Inc.
    • Kaneka Eurogentec S.A. (Kaneka)
    • TriLink BioTechnologies,LLC (Maravai Life Sciences)
    • BioAutomation
    • ATDBio Ltd.
    • Gene Design, Inc.
    • Eurofins Genomics

圖表

目錄

Global Oligonucleotide Synthesis Market: Overview

The oligonucleotide synthesis market is the highly growing market in developed and developing countries due to the fast growing life science industry, rising focus on genetics and genomics in the research and diagnostics applications, and rising application of oligonucleotides in therapeutics.

The market overview section of the report comprises qualitative analysis of the overall oligonucleotide synthesis market considering the factors determining the market dynamics such as drivers, restraints and opportunities, along with Porter's five force analysis and market attractiveness analysis. In addition, market opportunity analysis for product for global as well as Asia Pacific has also been provided. The report also comprises applications of oligonucleotides, and PEST analysis.

Global Oligonucleotide Synthesis Market: Segmentation

The global oligonucleotide synthesis market has been segmented on the basis of product, application and end user. The product segment is further segmented as, reagents & consumables, equipment, and synthesized oligonucleotide. The synthesized oligonucleotide segment is further segmented as, DNA oligonucleotides, RNA oligonucleotides, and others. Synthesized oligonucleotide segment accounted major share in 2016 of oligonucleotide synthesis market and expected to register high CAGR over forecast period.

By application, the global oligonucleotide synthesis market is segmented as, research, therapeutics, and diagnostics. The research accounted major share in 2016 of oligonucleotide synthesis market. The segment is further segmented as, Polymerase Chain Reaction (PCR), Next Generation Sequencing (NSG), and others. The therapeutic segment is fast growing segment by application over the forecast period owing to rising application of oligonucleotides in therapeutics. The segment is further segmented as antisense oligonucleotides, and nucleic acid aptamers. In market only few drugs are approved for therapeutic purpose and more than 100 are in various stages of clinical trials.

On the basis of end user, the global oligonucleotide synthesis market is segmented as biotechnology & pharmaceutical companies, research institutes, and diagnostic laboratories. Research institutes segment accounted major share in 2016 by end user in global oligonucleotide synthesis market. The biotechnology and pharmaceutical companies segment is expected to register high CAGR over forecast period. Increasing research and development activities, and rising demand for new drug development for rare and genetic disease is expected to drive growth of biotechnology and pharmaceutical companies segment over the forecast period. Moreover, rising application of oligonucleotides in diagnostics is expected to drive the growth of diagnostics segment over the forecast period.

The market for these product, application and end user has been extensively analyzed on the basis of factors such as usage pattern, sales revenue, and geographic presence of major market players and their product developments. The market size and forecast in terms of revenue (US$ million), for each of these segments, and the sub-segments have been provided for the period 2015 to 2025, considering 2016 as the base year. The report also provides the compounded annual growth rate (CAGR) for each segment for the forecast period 2017 to 2025.

Geographically, the oligonucleotide synthesis market has been classified into five segments namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The market size forecast for each region has been provided for the period 2015 to 2025, in terms of product, application and end user, along with the CAGR (%) for the forecast period 2017 to 2025.

Global Oligonucleotide Synthesis Market: Competitive Analysis

The report also provides a section on the competitive landscape, wherein the market share analysis of leading players in the global oligonucleotide synthesis market, in terms of percentage share in 2016 has been provided. The report concludes with the profiles of major players in the global oligonucleotide synthesis market such as Thermo Fisher Scientific, Sigma-Aldrich Corporation (a part of Merck KGaA), Integrated DNA Technologies, GE Healthcare, Kaneka Eurogentec S.A., Agilent Technologies, Applied Biosystems, BioAutomation, Eurofins Genomics, Gene Design, Inc. among others. The major market players are evaluated on various parameters such as company overview, financial overview, product portfolio, business strategies and recent developments.

The global Oligonucleotide Synthesis market is segmented as given below:

  • Oligonucleotide Synthesis Market, by Product Type
  • Reagents & Consumables
  • Equipment
  • Synthesized oligonucleotides
  • DNA oligonucleotides
  • RNA oligonucleotides
  • Others
  • Oligonucleotide Synthesis Market, by Application
  • Research
  • Polymerase Chain Reaction
  • Next Generation Sequencing
  • Others
  • Therapeutics
  • Antisense Oligonucleotides
  • Nucleic Acid Aptamers
  • Diagnostics
  • Oligonucleotide Synthesis Market, by End-users
  • Biotechnology & Pharmaceutical Companies
  • Research Institutes
  • Diagnostic Laboratories
  • Global Oligonucleotide Synthesis Market, by Region
  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East & Africa

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Oligonucleotide Synthesis Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Type Definition
    • 4.1.2. Industry Evolution / Developments
  • 4.2. Overview
  • 4.3. Key Market Indicators
  • 4.4. Market Dynamics
    • 4.4.1. Drivers
    • 4.4.2. Restraints
    • 4.4.3. Opportunity
  • 4.5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, 2015-2025
    • 4.5.1. Market Revenue Projections (US$ Mn)
  • 4.6. Oligonucleotide Synthesis Market - Global Supply Demand Scenario
  • 4.7. Porter's Five Force Analysis
  • 4.8. Value Chain Analysis
  • 4.9. Market Outlook
  • 4.10. Applications of Oligonucleotides
  • 4.11. PEST Analysis
  • 4.12. Pipeline Analysis

5. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Product Type

  • 5.1. Introduction & Definition
  • 5.2. Key Findings / Developments
  • 5.3. Key Trends
  • 5.4. Market Value Forecast by Product Type, 2015-2025
    • 5.4.1. Reagents & Consumables
    • 5.4.2. Equipment
    • 5.4.3. Synthesized oligonucleotides
      • 5.4.3.1. DNA Oligonucleotides
      • 5.4.3.2. RNA Oligonucleotides
      • 5.4.3.3. Others
  • 5.5. Market Attractiveness by Product Type

6. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Application

  • 6.1. Introduction & Definition
  • 6.2. Key Findings / Developments
  • 6.3. Key Trends
  • 6.4. Market Value Forecast by Application, 2015-2025
    • 6.4.1. Research
      • 6.4.1.1. Polymerase Chain Reaction
      • 6.4.1.2. Next Generation Sequencing
      • 6.4.1.3. Others
    • 6.4.2. Therapeutics
      • 6.4.2.1. Antisense Oligonucleotides
      • 6.4.2.2. Nucleic Acid Aptamers
    • 6.4.3. Diagnostics
  • 6.5. Market Attractiveness by Application

7. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By End User

  • 7.1. Introduction & Definition
  • 7.2. Key Findings / Developments
  • 7.3. Key Trends
  • 7.4. Market Value Forecast by End User, 2015-2025
    • 7.4.1. Biotechnology & Pharmaceutical Companies
    • 7.4.2. Research Institutes
    • 7.4.3. Diagnostic Laboratories
  • 7.5. Market Attractiveness by End User

8. Global Oligonucleotide Synthesis Market Analysis and Forecasts, By Region

  • 8.1. Key Findings
  • 8.2. Policies and Regulations
  • 8.3. Market Value Forecast by Region
    • 8.3.1. North America
    • 8.3.2. Europe
    • 8.3.3. Asia Pacific
    • 8.3.4. Latin America
    • 8.3.5. Middle East & Africa
  • 8.4. Market Attractiveness by Country/Region

9. North America Oligonucleotide Synthesis Market Analysis and Forecast

  • 9.1. Introduction
    • 9.1.1. Key Findings
    • 9.1.2. Key Trends
  • 9.2. Market Value Forecast by Product Type, 2015-2025
    • 9.2.1. Reagents & Consumables
    • 9.2.2. Equipment
    • 9.2.3. Synthesized oligonucleotides
      • 9.2.3.1. DNA Oligonucleotides
      • 9.2.3.2. RNA Oligonucleotides
      • 9.2.3.3. Others
  • 9.3. Market Value Forecast by Application, 2015-2025
    • 9.3.1. Research
      • 9.3.1.1. Polymerase Chain Reaction
      • 9.3.1.2. Next Generation Sequencing
      • 9.3.1.3. Others
    • 9.3.2. Therapeutics
      • 9.3.2.1. Antisense Oligonucleotides
      • 9.3.2.2. Nucleic Acid Aptamers
    • 9.3.3. Diagnostics
  • 9.4. Market Value Forecast by End User, 2015-2025
    • 9.4.1. Biotechnology & Pharmaceutical Companies
    • 9.4.2. Research Institutes
    • 9.4.3. Diagnostic Laboratories
  • 9.5. Market Value Forecast by Country, 2015-2025
    • 9.5.1. U.S.
    • 9.5.2. Canada
  • 9.6. Market Attractiveness Analysis
    • 9.6.1. By Product Type
    • 9.6.2. By Application
    • 9.6.3. By End User
    • 9.6.4. By Country

10. Europe Oligonucleotide Synthesis Market Analysis and Forecast

  • 10.1. Introduction
    • 10.1.1. Key Findings
    • 10.1.2. Key Trends
  • 10.2. Market Value Forecast by Product Type, 2015-2025
    • 10.2.1. Reagents & Consumables
    • 10.2.2. Equipment
    • 10.2.3. Synthesized oligonucleotides
      • 10.2.3.1. DNA Oligonucleotides
      • 10.2.3.2. RNA Oligonucleotides
      • 10.2.3.3. Others
  • 10.3. Market Value Forecast by Application, 2015-2025
    • 10.3.1. Research
      • 10.3.1.1. Polymerase Chain Reaction
      • 10.3.1.2. Next Generation Sequencing
      • 10.3.1.3. Others
    • 10.3.2. Therapeutics
      • 10.3.2.1. Antisense Oligonucleotides
      • 10.3.2.2. Nucleic Acid Aptamers
    • 10.3.3. Diagnostics
  • 10.4. Market Value Forecast by End User, 2015-2025
    • 10.4.1. Biotechnology & Pharmaceutical Companies
    • 10.4.2. Research Institutes
    • 10.4.3. Diagnostic Laboratories
  • 10.5. Market Value Forecast by Country, 2015-2025
    • 10.5.1. Germany
    • 10.5.2. U.K.
    • 10.5.3. France
    • 10.5.4. Italy
    • 10.5.5. Spain
    • 10.5.6. Rest of Europe
  • 10.6. Market Attractiveness Analysis
    • 10.6.1. By Product Type
    • 10.6.2. By Application
    • 10.6.3. By End User
    • 10.6.4. By Country

11. Asia Pacific Oligonucleotide Synthesis Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
    • 11.1.2. Key Trends
  • 11.2. Market Value Forecast by Product Type, 2015-2025
    • 11.2.1. Reagents & Consumables
    • 11.2.2. Equipment
    • 11.2.3. Synthesized oligonucleotides
      • 11.2.3.1. DNA Oligonucleotides
      • 11.2.3.2. RNA Oligonucleotides
      • 11.2.3.3. Others
  • 11.3. Market Value Forecast by Application, 2015-2025
    • 11.3.1. Research
      • 11.3.1.1. Polymerase Chain Reaction
      • 11.3.1.2. Next Generation Sequencing
      • 11.3.1.3. Others
    • 11.3.2. Therapeutics
      • 11.3.2.1. Antisense Oligonucleotides
      • 11.3.2.2. Nucleic Acid Aptamers
    • 11.3.3. Diagnostics
  • 11.4. Market Value Forecast by End User, 2015-2025
    • 11.4.1. Biotechnology & Pharmaceutical Companies
    • 11.4.2. Research Institutes
    • 11.4.3. Diagnostic Laboratories
  • 11.5. Market Value Forecast by Country, 2015-2025
    • 11.5.1. China
    • 11.5.2. India
    • 11.5.3. Japan
    • 11.5.4. Australia & New Zealand
    • 11.5.5. Rest of Asia Pacific
  • 11.6. Market Attractiveness Analysis
    • 11.6.1. By Product Type
    • 11.6.2. By Application
    • 11.6.3. By End User
    • 11.6.4. By Country

12. Latin America Oligonucleotide Synthesis Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
    • 12.1.2. Key Trends
  • 12.2. Market Value Forecast by Product Type, 2015-2025
    • 12.2.1. Reagents & Consumables
    • 12.2.2. Equipment
    • 12.2.3. Synthesized oligonucleotides
      • 12.2.3.1. DNA Oligonucleotides
      • 12.2.3.2. RNA Oligonucleotides
      • 12.2.3.3. Others
  • 12.3. Market Value Forecast by Application, 2015-2025
    • 12.3.1. Research
      • 12.3.1.1. Polymerase Chain Reaction
      • 12.3.1.2. Next Generation Sequencing
      • 12.3.1.3. Others
    • 12.3.2. Therapeutics
      • 12.3.2.1. Antisense Oligonucleotides
      • 12.3.2.2. Nucleic Acid Aptamers
    • 12.3.3. Diagnostics
  • 12.4. Market Value Forecast by End User, 2015-2025
    • 12.4.1. Biotechnology & Pharmaceutical Companies
    • 12.4.2. Research Institutes
    • 12.4.3. Diagnostic Laboratories
  • 12.5. Market Value Forecast by Country, 2015-2025
    • 12.5.1. Brazil
    • 12.5.2. Mexico
    • 12.5.3. Rest of Latin America
  • 12.6. Market Attractiveness Analysis
    • 12.6.1. By Product Type
    • 12.6.2. By Application
    • 12.6.3. By End User
    • 12.6.4. By Country

13. Middle East & Africa Oligonucleotide Synthesis Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
    • 13.1.3. Key Trends
  • 13.2. Market Value Forecast by Product Type, 2015-2025
    • 13.2.1. Reagents & Consumables
    • 13.2.2. Equipment
    • 13.2.3. Synthesized oligonucleotides
      • 13.2.3.1. DNA Oligonucleotides
      • 13.2.3.2. RNA Oligonucleotides
      • 13.2.3.3. Others
  • 13.3. Market Value Forecast by Application, 2015-2025
    • 13.3.1. Research
      • 13.3.1.1. Polymerase Chain Reaction
      • 13.3.1.2. Next Generation Sequencing
      • 13.3.1.3. Others
    • 13.3.2. Therapeutics
      • 13.3.2.1. Antisense Oligonucleotides
      • 13.3.2.2. Nucleic Acid Aptamers
    • 13.3.3. Diagnostics
  • 13.4. Market Value Forecast by End User, 2015-2025
    • 13.4.1. Biotechnology & Pharmaceutical Companies
    • 13.4.2. Research Institutes
    • 13.4.3. Diagnostic Laboratories
  • 13.5. Market Value Forecast by Country, 2015-2025
    • 13.5.1. Saudi Arabia
    • 13.5.2. South Africa
    • 13.5.3. UAE
    • 13.5.4. Rest of Middle East & Africa
  • 13.6. Market Attractiveness Analysis
    • 13.6.1. By Product Type
    • 13.6.2. By Application
    • 13.6.3. By End User
    • 13.6.4. By Country

14. Competition Landscape

  • 14.1. Market Player - Competition Matrix (By Tier and Size of companies)
  • 14.2. Market Share Analysis by Company (2016)
  • 14.3. Company Profiles (Details - Overview, Financials, Recent Developments, Strategy)
    • 14.3.1. GE Healthcare
      • 14.3.1.1. Financial Overview
      • 14.3.1.2. Product Portfolio
      • 14.3.1.3. SWOT Analysis
      • 14.3.1.4. Strategic Overview
    • 14.3.2. Thermo Fisher Scientific
      • 14.3.2.1. Financial Overview
      • 14.3.2.2. Product Portfolio
      • 14.3.2.3. SWOT Analysis
      • 14.3.2.4. Strategic Overview
    • 14.3.3. Agilent Technologies, Inc.
      • 14.3.3.1. Financial Overview
      • 14.3.3.2. Product Portfolio
      • 14.3.3.3. SWOT Analysis
      • 14.3.3.4. Strategic Overview
    • 14.3.4. Merck KGaA
      • 14.3.4.1. Financial Overview
      • 14.3.4.2. Product Portfolio
      • 14.3.4.3. SWOT Analysis
      • 14.3.4.4. Strategic Overview
    • 14.3.5. Integrated DNA Technologies, Inc.
      • 14.3.5.1. Financial Overview
      • 14.3.5.2. Product Portfolio
      • 14.3.5.3. SWOT Analysis
      • 14.3.5.4. Strategic Overview
    • 14.3.6. Kaneka Eurogentec S.A. (Kaneka Corporation)
      • 14.3.6.1. Financial Overview
      • 14.3.6.2. Product Portfolio
      • 14.3.6.3. SWOT Analysis
      • 14.3.6.4. Strategic Overview
    • 14.3.7. TriLink BioTechnologies,LLC (Maravai Life Sciences)
      • 14.3.7.1. Financial Overview
      • 14.3.7.2. Product Portfolio
      • 14.3.7.3. SWOT Analysis
      • 14.3.7.4. Strategic Overview
    • 14.3.8. BioAutomation
      • 14.3.8.1. Financial Overview
      • 14.3.8.2. Product Portfolio
      • 14.3.8.3. SWOT Analysis
      • 14.3.8.4. Strategic Overview
    • 14.3.9. ATDBio Ltd.
      • 14.3.9.1. Financial Overview
      • 14.3.9.2. Product Portfolio
      • 14.3.9.3. SWOT Analysis
      • 14.3.9.4. Strategic Overview
    • 14.3.10. Gene Design, Inc.
      • 14.3.10.1. Financial Overview
      • 14.3.10.2. Product Portfolio
      • 14.3.10.3. SWOT Analysis
      • 14.3.10.4. Strategic Overview
    • 14.3.11. Eurofins Genomics
      • 14.3.11.1. Financial Overview
      • 14.3.11.2. Product Portfolio
      • 14.3.11.3. SWOT Analysis
      • 14.3.11.4. Strategic Overview

List of Tables

  • Table 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 02: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 03: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 04: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 05: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 06: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 07: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Region, 2015-2025
  • Table 08: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 09: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 10: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 11: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 12: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 13: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 14: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 15: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 16: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 17: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 18: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 19: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 20: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 21: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 22: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 23: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 24: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 25: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 26: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 27: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 28: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 29: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 30: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 31: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 32: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 33: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 34: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 35: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025
  • Table 36: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Country, 2015-2025
  • Table 37: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Product Type, 2015-2025
  • Table 38: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Synthesized Oligonucleotide, 2015-2025
  • Table 39: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Application, 2015-2025
  • Table 40: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Research, 2015-2025
  • Table 41: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by Therapeutic, 2015-2025
  • Table 42: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, by End-user, 2015-2025

List of Figures

  • Figure 01: Global Oligonucleotide Synthesis Market Size (US$ Mn) Forecast, 2015-2025
  • Figure 02: Global oligonucleotide Synthesis Market Value Share, by Product Type (2016)
  • Figure 03: Global oligonucleotide Synthesis Market Value Share, by Application (2016)
  • Figure 04: Global oligonucleotide Synthesis Market Value Share, by End User (2016)
  • Figure 05: Global oligonucleotide Synthesis Market Value Share, by Region (2016)
  • Figure 06: Global Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 07: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Reagents & Consumables, 2015-2025
  • Figure 08: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Equipment, 2015-2025
  • Figure 09: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Synthesized Oligonucleotides, 2015-2025
  • Figure 10: Global Oligonucleotide Synthesis Market Attractiveness, by Product Type
  • Figure 11: Global Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 12: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research, 2015-2025
  • Figure 13: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Therapeutics, 2015-2025
  • Figure 14: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2015-2025
  • Figure 15: Global Oligonucleotide Synthesis Market Attractiveness, by Application
  • Figure 16: Global Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 17: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Biotechnology & Pharmaceutical Companies, 2015-2025
  • Figure 18: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Research Institutes, 2015-2025
  • Figure 19: Global Oligonucleotide Synthesis Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015-2025
  • Figure 20: Global Oligonucleotide Synthesis Market Attractiveness, by End-user
  • Figure 21: Global Oligonucleotide Synthesis Market Value Share, by Region, 2017 and 2025
  • Figure 22: Global Oligonucleotide Synthesis Market Attractiveness, by Region, 2017-2025
  • Figure 23: North America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 24: North America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 25: North America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017-2025
  • Figure 26: North America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 27: North America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017-2025
  • Figure 28: North America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 29: North America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017-2025
  • Figure 30: North America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 31: North America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017-2025
  • Figure 32: Europe Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 33: Europe Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 34: Europe Oligonucleotide Synthesis Market Attractiveness, by Country, 2017-2025
  • Figure 35: Europe Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 36: Europe Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017-2025
  • Figure 37: Europe Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 38: Europe Oligonucleotide Synthesis Market Attractiveness, by Application, 2017-2025
  • Figure 39: Europe Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 40: Europe Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017-2025
  • Figure 41: Asia Pacific Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 42: Asia Pacific Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 43: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Country, 2017-2025
  • Figure 44: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 45: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017-2025
  • Figure 46: Asia Pacific Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 47: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by Application, 2017-2025
  • Figure 48: Asia Pacific Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 49: Asia Pacific Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017-2025
  • Figure 50: Latin America Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 51: Latin America Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 52: Latin America Oligonucleotide Synthesis Market Attractiveness, by Country, 2017-2025
  • Figure 53: Latin America Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 54: Latin America Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017-2025
  • Figure 55: Latin America Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 56: Latin America Oligonucleotide Synthesis Market Attractiveness, by Application, 2017-2025
  • Figure 57: Latin America Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 58: Latin America Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017-2025
  • Figure 59: Middle East & Africa Oligonucleotide Synthesis Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015-2025
  • Figure 60: Middle East & Africa Oligonucleotide Synthesis Market Value Share Analysis, by Country, 2017 and 2025
  • Figure 61: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Country, 2017-2025
  • Figure 62: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Product Type, 2017 and 2025
  • Figure 63: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Product Type, 2017-2025
  • Figure 64: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by Application, 2017 and 2025
  • Figure 65: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by Application, 2017-2025
  • Figure 66: Middle East & Africa Oligonucleotide Synthesis Market Value Share, by End-user, 2017 and 2025
  • Figure 67: Middle East & Africa Oligonucleotide Synthesis Market Attractiveness, by End-user, 2017-2025
  • Figure 68: Global Oligonucleotide Synthesis Market Share, by Company, 2016
Back to Top